OrbiMed’s Ventyx Biosciences VTYX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,870,456
| Closed | -$10.3M | – | 118 |
|
|
2024
Q1 | $10.3M | Buy |
+1,870,456
| New | +$10.3M | 0.19% | 79 |
|
|
2023
Q4 | – | Sell |
-340,384
| Closed | -$11.8M | – | 129 |
|
|
2023
Q3 | $11.8M | Sell |
340,384
-200,600
| -37% | -$6.97M | 0.25% | 76 |
|
|
2023
Q2 | $17.7M | Sell |
540,984
-44,016
| -8% | -$1.44M | 0.32% | 74 |
|
|
2023
Q1 | $19.6M | Sell |
585,000
-340,000
| -37% | -$11.4M | 0.38% | 68 |
|
|
2022
Q4 | $30.3M | Buy |
925,000
+700,000
| +311% | +$23M | 0.58% | 57 |
|
|
2022
Q3 | $7.86K | Sell |
225,000
-1,064,280
| -83% | -$37.2K | 0.15% | 92 |
|
|
2022
Q2 | $15.8K | Hold |
1,289,280
| – | – | 0.29% | 74 |
|
|
2022
Q1 | $17.5M | Hold |
1,289,280
| – | – | 0.28% | 71 |
|
|
2021
Q4 | $25.6M | Buy |
+1,289,280
| New | +$25.6M | 0.33% | 74 |
|